AI Article Synopsis

  • A new extension to the 'Cobiveco' biventricular coordinate system has been introduced to improve anatomical registration of heart ventricles by including complex regions like outflow tracts and valve annuli.
  • The proposed CobivecoX system employs a unique algorithm to identify intervalvular bridges and assign specific coordinates for precise local positioning in these areas.
  • Validation of this method was conducted using curated three-dimensional models from cardiac MRI, ensuring that universal cardiac coordinates can be effectively applied to diverse ventricular shapes relevant to both normal hearts and those with congenital conditions.

Article Abstract

Universal coordinate systems have been proposed to facilitate anatomic registration between three-dimensional images, data and models of the ventricles of the heart. However, current universal ventricular coordinate systems do not account for the outflow tracts and valve annuli where the anatomy is complex. Here we propose an extension to the 'Cobiveco' biventricular coordinate system that also accounts for the intervalvular bridges of the base and provides a tool for anatomically consistent registration between widely varying biventricular shapes. CobivecoX uses a novel algorithm to separate intervalvular bridges and assign new coordinates, including an inflow-outflow coordinate, to describe local positions in these regions uniquely and consistently. Anatomic consistency of registration was validated using curated three-dimensional biventricular shape models derived from cardiac MRI measurements in normal hearts and hearts from patients with congenital heart diseases. This new method allows the advantages of universal cardiac coordinates to be used for three-dimensional ventricular imaging data and models that include the left and right ventricular outflow tracts and valve annuli.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11227738PMC
http://dx.doi.org/10.1016/j.media.2024.103091DOI Listing

Publication Analysis

Top Keywords

valve annuli
12
biventricular coordinate
8
coordinate system
8
congenital heart
8
coordinate systems
8
data models
8
outflow tracts
8
tracts valve
8
intervalvular bridges
8
coordinate
5

Similar Publications

In the valve-in-valve transcatheter aortic valve replacement (ViV-TAVR) era, implanting a larger-sized valve during the initial aortic valve replacement is important. For smaller aortic annuli, combining aortic annular and left ventricular outflow tract (LVOT) enlargement is essential. The Y-incision procedure helps achieve implantation of a 2-size larger valve.

View Article and Find Full Text PDF

Background: The management of Transcatheter Aortic Valve Implantation (TAVI) patients with a small aortic annulus (SAA) postures a substantial challenge, increasing the risk of patient- prosthesis mismatch (PPM) and overall mortality.

Aims: This study aimed to compare the hemodynamic and clinical outcomes of transcatheter balloon-expandable valve (BEV) versus transcatheter self-expandable valve (SEV) in SAA.

Methods: We conducted propensity score matching (PSM) of severe AS patients with SAA who underwent trans-femoral TAVR and enrolled to the Israeli TAVR registry between the years 2008 and 2023.

View Article and Find Full Text PDF

Background: It remains unclear what proportion of patients with tricuspid regurgitation (TR) are suitable candidates for transcatheter tricuspid valve intervention (TTVI) in clinical practice.

Objectives: The aim of this study was to ascertain the prevalence of eligibility for tricuspid transcatheter edge-to-edge repair (T-TEER) and transcatheter tricuspid valve replacement (TTVR) devices among patients with TR.

Methods: The tricuspid valve anatomy of all consecutive patients with TR who were considered for TTVI in local heart team conferences was retrospectively reviewed.

View Article and Find Full Text PDF

Despite the widespread adoption of valve-in-valve transcatheter aortic valve replacement (VIV-TAVR) for patients with failed aortic bioprosthesis, the effectiveness of this treatment for Japanese patients frequently associated with small aortic annuli remains unclear. From December-2011 to October-2022, 41 consecutive patients undergoing VIV-TAVR were enrolled in this study. The endpoints were technical success, device success, early safety, and two-year mortality according to implanted surgical valve size (small valves: 19-mm and 21-mm, n = 23; large valves: 23-mm and 25-mm, n = 18).

View Article and Find Full Text PDF
Article Synopsis
  • The Myval is a transcatheter heart valve developed by Meril Life Sciences that features an operator-friendly design for easier delivery and precise deployment.
  • It has shown effectiveness and safety in clinical studies, making it suitable for various complex heart valve procedures, including aortic valve implantation and pulmonary valve replacement.
  • The advancement of Myval signifies a step forward in cardiology, with a need for further long-term studies to confirm its benefits in improving patient outcomes and quality of life.*
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!